1G6-D7, a selective anti-HSP90α monoclonal antibody, was previously reported to attenuate pulmonary fibrosis by inhibiting the MAPK signaling pathway (Dong et al., 2017). The gene discussed is HSP90AA1; the disease is pulmonary fibrosis.